Seelos Therapeutics, Inc. Weighted Average Basic Shares Outstanding, Pro Forma
Seelos Therapeutics, Inc. reported Weighted Average Basic Shares Outstanding, Pro Forma of 27.46 million shares for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-18.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageBasicSharesOutstandingProForma · last filed 2013-08-14
- Seelos Therapeutics, Inc. weighted average basic shares outstanding, pro forma for the quarter ending 2012-09-30 was 29.26M shares, a 44.81% increase year-over-year.
- Seelos Therapeutics, Inc. weighted average basic shares outstanding, pro forma for the quarter ending 2012-06-30 was 26.63M shares.
- Seelos Therapeutics, Inc. weighted average basic shares outstanding, pro forma for the quarter ending 2012-03-31 was 24.01M shares.
- Seelos Therapeutics, Inc. weighted average basic shares outstanding, pro forma for the quarter ending 2011-09-30 was 20.20M shares.
- Seelos Therapeutics, Inc. weighted average basic shares outstanding, pro forma for fiscal 2012 was 27.46M shares, a 37.13% increase from fiscal 2011.
- Seelos Therapeutics, Inc. weighted average basic shares outstanding, pro forma for fiscal 2011 was 20.02M shares.
| Period end | Weighted Average Basic Shares Outstanding, Pro Forma 3 month | Weighted Average Basic Shares Outstanding, Pro Forma 6 month | Weighted Average Basic Shares Outstanding, Pro Forma 9 month | Weighted Average Basic Shares Outstanding, Pro Forma 12 month |
|---|---|---|---|---|
| 2012-12-31 | 27.46M shares 10-K · filed 2013-03-18 | |||
| 2012-09-30 | 29.26M shares 10-Q · filed 2012-11-08 | 26.65M shares 10-Q · filed 2012-11-08 | ||
| 2012-06-30 | 26.63M shares 10-Q · filed 2013-08-14 | 23.34M shares 10-Q · filed 2013-08-14 | ||
| 2012-03-31 | 24.01M shares 10-Q · filed 2013-05-10 | |||
| 2011-12-31 | 20.02M shares 10-K · filed 2013-03-18 | |||
| 2011-09-30 | 20.20M shares 10-Q · filed 2012-11-08 | 19.72M shares 10-Q · filed 2012-11-08 |